Skip to main content
GMED
NYSE Life Sciences

Globus Medical Buys Synaptive Medical to Bolster Cranial Neurosurgery Franchise

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$79.58
Mkt Cap
$10.685B
52W Low
$59.51
52W High
$101.398
52W Position info
34% above low
Off High info
22% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

GMED sits 34% above its 52-week low of $59.51.

Summary

Globus Medical has completed its acquisition of Synaptive Medical, a cranial neurosurgery specialist, adding robotics and imaging technology to its spine-heavy portfolio. This is the second bolt-on deal in roughly two months, following the August acquisition of AI-driven digital health company Higgs Boson Health. No purchase price or deal terms were disclosed, so the immediate financial impact is unclear; the strategic logic is cross-selling Synaptive's cranial navigation and visualization tools through Globus's existing hospital relationships. Globus has the balance sheet to absorb a modest tuck-in, having posted Q2 2026 revenue of $789.6M with operating income more than doubling to $182.4M. Watch for deal terms in the forthcoming 8-K and any guidance update on the next earnings call.

At the time of this announcement, GMED was trading at $79.58 on NYSE in the Life Sciences sector, with a market capitalization of approximately $10.7B. The 52-week trading range was $59.51 to $101.40. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

GMED - Latest Insights

GMED
Nov 05, 2026, 5:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $77.60
Real-time Price: $66.89 info
Change: -$10.71 (-14%) info
Market Cap: $8.861B info
GMED
Nov 05, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $80.31
Real-time Price: $66.89 info
Change: -$13.42 (-17%) info
Market Cap: $8.861B info
GMED
Nov 05, 2026, 4:02 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $81.52
Real-time Price: $66.89 info
Change: -$14.63 (-18%) info
Market Cap: $8.861B info
GMED
Aug 26, 2026, 5:57 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $82.96
Real-time Price: $66.89 info
Change: -$16.07 (-19%) info
Market Cap: $8.861B info
GMED
Aug 06, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $84.00
Real-time Price: $66.89 info
Change: -$17.11 (-20%) info
Market Cap: $8.861B info